solutions real-world-and-late-phase Clinical Development Related Topics 
XTalks
MARCH 5, 2021
The acquisition will see ICON plc, global provider of development and commercialization services to the pharmaceutical, biotechnology and medical device industries, expand its portfolio to leverage PRA’s mobile and connected health platforms, along with its data and information solutions. Accelerating Development.
The Pharma Data
JULY 23, 2021
Nasdaq: BIIB) today announced it will share multiple oral and poster presentations from its Alzheimer’s disease clinical development portfolio at the Alzheimer’s Association International Conference (AAIC), which will be held in Denver, Colorado and online July 26-30, 2021. Biogen Inc.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
XTalks
SEPTEMBER 14, 2020
By the end of August, the World Health Organization (WHO) counted 33 vaccine candidates in some stage of clinical trial evaluation. What’s at stake is nothing short of a world full of people who’ll need not one but likely two shots of a vaccine to bring the pandemic to a halt. Moderna’s COVID-19 Vaccine.
XTalks
AUGUST 2, 2023
In a world where health is paramount, the pharmaceutical industry stands as a formidable pillar, relentlessly pursuing scientific breakthroughs and life-saving innovations. is a global pharmaceutical company, working across both developed and emerging markets. 2022 Revenue: Pfizer reported an annual revenue of $100.33 billion, a 42.74
Expert insights. Personalized for you.
98 
Let's personalize your content